摘要
目的评价厄贝沙坦联合氢氯噻嗪治疗重度高血压的疗效和安全性。方法选择我院2007～2009年76例门诊重度高血压病患者,随机分为厄贝沙坦联合氢氯噻嗪组(38例)和厄贝沙坦组(38例),用药4周后,观察两组的疗效和不良反应。结果厄贝沙坦联合氢氯噻嗪组有效率为94.74%,氢氯噻嗪组有效率为84.21%,两组比较,差异显著(P<0.05),且两组不良反应无明显区别。结论厄贝沙坦联合氢氯噻嗪疗效好,是治疗重度高血压安全有效的方法之一。
Objective To Evaluate the efficacy and safety of Irbesartsn plus Dihydro Chlorothiazide in treating severe hyperpiesia. Methods 76 cases of out-patients with severe hypertension were randomly divided into two groups. One group was given Irbesartan plus Dihydrochlorethiazide for 4 weeks,the other group was given Irbesartan for 4 weeks. The therapeutic effect and adverse reaction was observed. Results The blood pressure control rate was 94.74% in Irbesartan plus Hydrochlorothiazide group and 84.21% in Irbesartan,and there was no significant difference in adverse reactions between two groups. Conclusion The combination of Irbesartan plus DihydroChlorothiazide has definite benefit in patients with severe hyperpiesia
出处
《中国现代医生》
2011年第11期150-151,共2页
China Modern Doctor
关键词
厄贝沙坦
氢氯噻嗪
高血压
Irbesartan
Dihydrochlorothiazide
Hyperpiesia
